The latest closing stock price for Tempest Therapeutics as of July 17, 2025 is 6.66.
An investor who bought $1,000 worth of Tempest Therapeutics stock at the IPO in 2012 would have $-1,000 today, roughly -1 times their original investment - a -46.37% compound annual growth rate over 13 years.
The all-time high Tempest Therapeutics stock closing price was 156370.00 on March 24, 2015.
The Tempest Therapeutics 52-week high stock price is 28.35, which is 325.7% above the current share price.
The Tempest Therapeutics 52-week low stock price is 5.35, which is 19.7% below the current share price.
The average Tempest Therapeutics stock price for the last 52 weeks is 11.93.
An investor who bought $1,000 worth of Tempest Therapeutics stock at the IPO in 2012 would have $-1,000 today, roughly -1 times their original investment - a -46.37% compound annual growth rate over 13 years.
The all-time high Tempest Therapeutics stock closing price was 156370.00 on March 24, 2015.
The Tempest Therapeutics 52-week high stock price is 28.35, which is 325.7% above the current share price.
The Tempest Therapeutics 52-week low stock price is 5.35, which is 19.7% below the current share price.
The average Tempest Therapeutics stock price for the last 52 weeks is 11.93.